CXDO insider trade: COO option exercise at $2.25, sale at $7.174
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Crexendo (CXDO) Form 4: Chief Operating Officer Douglas Walter Gaylor exercised 10,000 stock options at $2.25 and sold 10,000 common shares at a weighted average price of $7.174. Following these transactions, he directly beneficially owned 243,135 common shares and held 22,000 derivative securities (options) after the exercise.
The sale was made under a Rule 10b5-1(c) trading plan entered on December 11, 2024. The options exercised relate to grants that vested over 36 equal monthly installments beginning on March 12, 2019, and carry a stated expiration of February 12, 2026.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 10,000 shares ($71,740)
Net Sell
3 txns
Insider
Gaylor Douglas Walter
Role
Chief Operating Officer
Sold
10,000 shs ($72K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options | 10,000 | $2.25 | $23K |
| Sale | Common stock | 10,000 | $7.174 | $72K |
| Exercise | Common Stock | 10,000 | $2.25 | $23K |
Holdings After Transaction:
Stock Options — 22,000 shares (Direct);
Common stock — 243,135 shares (Direct);
Common Stock — 253,135 shares (Direct)
Footnotes (1)
- This sale was made pursuant to a plan intended to comply with Rule 10b5-1(c), previously entered into on December 11, 2024, at which time Mr. Gaylor was not aware of material nonpublic information. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.15 to $7.19. Details can be provided upon request. The stock options vested over 36 equal monthly installments beginning on 3/12/2019.
FAQ
What did CXDO's COO report on Form 4?
He exercised 10,000 stock options at $2.25 and sold 10,000 shares at a $7.174 weighted average price.
When did the transactions occur for CXDO?
The option exercise is listed on 11/07/2025 (Table I) and also shown in Table II on 11/10/2025; the share sale occurred on 11/10/2025.
What is the status of the reporting person's remaining options?
He held 22,000 derivative securities (options) after the exercise; the options have a stated expiration of 02/12/2026.
Was the sale under a 10b5-1 plan for CXDO?
Yes. The sale was made pursuant to a Rule 10b5-1(c) plan entered on December 11, 2024.